Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000421138

Medchemexpress LLC Sonolisib | 502632-66-8 | 5 MG
SDP

Supplier:  Medchemexpress LLC HYN67755MG

Encompass_Preferred

Sonolisib (PX-866), an improved Wortmannin analogue, is an oral, irreversible, and pan-isoform inhibitor of PI3K. It inhibits the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and activation of the PI3K/Akt signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. It exhibits antitumor activity.

  • Oral, irreversible, and pan-isoform inhibitor of PI3K
  • Inhibits production of secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3)
  • Inhibits activation of PI3K/Akt signaling pathway
  • Exhibits antitumor activity
  • May inhibit tumor cell growth and survival

Catalog No. 50-004-21138


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.